BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8627548)

  • 1. Pharmacological characterization of tachykinin NK2 receptors on isolated human urinary bladder, prostatic urethra and prostate.
    Palea S; Corsi M; Artibani W; Ostardo E; Pietra C
    J Pharmacol Exp Ther; 1996 May; 277(2):700-5. PubMed ID: 8627548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinin NK-2 receptors in child urinary bladder.
    Zeng XP; Burcher E
    J Urol; 1996 Mar; 155(3):1104-7. PubMed ID: 8583573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats.
    Lecci A; Giuliani S; Patacchini R; Maggi CA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1327-32. PubMed ID: 8383746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum.
    Zagorodnyuk V; Santicioli P; Turini D; Maggi CA
    Neuropeptides; 1997 Jun; 31(3):265-71. PubMed ID: 9243524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
    Hall JM; Morton IK
    Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
    Abdel-Gawad M; Dion SB; Elhilali MM
    J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors.
    Lippe I; Wachter CH; Holzer P
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1294-302. PubMed ID: 9190865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
    Tramontana M; Patacchini R; Lecci A; Giuliani S; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):293-300. PubMed ID: 9774215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
    Warner FJ; Comis A; Miller RC; Burcher E
    Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
    Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line.
    Subramanian N; Ruesch C; Bertrand C
    Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.